Using such an ALT threshold is open to debate, especially when previous studies had shown CHB patients with a normal ALT at the upper range had an increased risk of long-term cirrhotic complications and HCC [25], [26]. The gene discussed is GPT; the disease is hepatocellular carcinoma.